Devdiscourse
Development News Edition
Give Feedback
write for Us

Health News Round-up: Humira patent dispute, Talc cancer case, Congo's Ebola outbreak

The most concerning area is the city of Beni in Congo's North Kivu province where dozens of people who may have been exposed to the deadly disease are hiding from health workers, emergency response chief Peter Salama said.


Devdiscourse News Desk
Updated: 12-10-2018 11:53 IST
Health News Round-up: Humira patent dispute, Talc cancer case, Congo's Ebola outbreak

Democratic Republic of Congo's Ebola outbreak is expected to last several months and could spread to Uganda or Rwanda. (Image Credit: Twitter)

Abbvie settles Humira patent disputes with Novartis unit

Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of the blockbuster drug, Humira. Abbvie, however, did not disclose details regarding the royalties it will receive from Novartis generics unit, Sandoz, as part of the agreement.

Doctors move away from using live animals for trauma surgery training

An initiative to replace the use of live animals with a human simulator for trauma surgery practice got training programs in more than 20 countries to make the switch, saving them money in the process, researchers say. The simulators are anatomically realistic and allow trainees to practice surgical skills and invasive procedures such as chest tube insertion, airway punctures, and draining fluids from the body, the study authors write in the Journal of Surgical Education.

Jury clears J&J of liability in New Jersey talc cancer case

A New Jersey jury on Thursday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer. After less than a day of deliberations, the jury in New Brunswick, New Jersey rejected claims by Rosalind Henry and her husband, who had alleged that Henry's mesothelioma, cancer associated with asbestos exposure, was caused by the company's talc products.

C-section births rise rapidly to more than 20 percent worldwide

Rates of caesarean section births almost doubled between 2000 and 2015 – from 12 to 21 per cent worldwide - new research has found, with the life-saving surgery unavailable to many women in poor countries while often over-used in richer ones. The research, published in The Lancet medical journal on Thursday, found that 60 per cent of countries overuse C-sections and 25 per cent under-use them, suggesting that recommendations for their use in cases of medical need are widely ignored.

Public seems to know value of clinical trials, but not how they work

Patients, their families and friends may see clinical trial research as important, yet they don't know much about the research process and see trial participation as burdensome, a new study suggests. About 85 per cent of respondents in the new study said clinical research is important to developing new drugs, and 90 per cent thought participating in a trial is generally safe. But only 18 per cent had actually done so, researchers report in JAMA Network Open.

Asthma during pregnancy tied to postpartum depression risk

Women who have asthma during their pregnancies are more likely to experience postpartum depression after delivery, a large Canadian study suggests. Physicians should watch for signs of depression in their pregnant patients with asthma so treatment and coping strategies can start early, the authors write in The Journal of Allergy and Clinical Immunology: In Practice.

Bristol-Myers to invest in Compugen, collaborate in clinical trials

Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumours. The trials will evaluate the safety and tolerability of Compugen's COM701, an investigational antibody, in combination with Bristol-Myers Squibb's immune checkpoint inhibitor Opdivo.

WHO sees Congo's Ebola outbreak lasting 3-4 months at least

Democratic Republic of Congo's Ebola outbreak is expected to last several months and could spread to Uganda or Rwanda, which are well prepared but have not approved the use of a vaccine, the World Health Organization said on Thursday. The most concerning area is the city of Beni in Congo's North Kivu province where dozens of people who may have been exposed to the deadly disease are hiding from health workers, emergency response chief Peter Salama said.

Medtronic disables pacemaker programmer updates over hack concern

Medical device maker Medtronic Plc has disabled internet updates for some 34,000 CareLink programming devices that healthcare providers around the world use to access implanted pacemakers, saying the system was vulnerable to cyber attacks. The company said it knows of no cases where the vulnerability had been exploited by hackers in a letter sent to physicians this week, which was labelled "urgent medical device correction."

Child refugees in Nauru camp struggle to eat, drink, talk: MSF

The mental health of refugees detained by Australia on the Pacific island of Nauru has deteriorated so badly that some children are in a "semi-comatose state", unable to eat, drink or talk, Médecins Sans Frontières (MSF) said on Thursday. Nauru is one of two Pacific nations where Australia detains hundreds of asylum seekers intercepted while trying to reach the country by boat, a policy widely criticized by the United Nations and rights groups.

(With inputs from agencies.)


POST A COMMENT